Characteristic endoscopic findings in Helicobacter pylori diagnosis in clinical practice
Mitsushige Sugimoto Masaki Murata Kazunari Murakami Yoshio Yamaoka Takashi Kawai a Division of Genome-Wide Infectious Diseases,Research Center for GLOBAL and LOCAL Infectious Disease,Oita University,Yufu,Japanb Department of Gastroenterology,National Hospital Organization Kyoto Medical Center,Kyoto,Japanc Department of Gastroenterology,Oita University,Yufu,Japand Department of Environmental and Preventive Medicine,Oita University,Yufu,Japane Department of Gastroenterological Endoscopy,Tokyo Medical University Hospital,Shinjuku,Japan
DOI: https://doi.org/10.1080/17474124.2024.2395317
2024-08-24
Expert Review of Gastroenterology & Hepatology
Abstract:Introduction Helicobacter pylori is a major risk factor for gastric cancer. In addition to eradication therapy, early-phase detection of gastric cancer through screening programs using high-vision endoscopy is also widely known to reduce mortality. Although European and US guidelines recommend evaluation of atrophy and intestinal metaplasia by high-vision endoscopy and pathological findings, the guideline used in Japan – the Kyoto classification of gastritis – is based on endoscopic evaluation, and recommends the grading of risk factors. This system requires classification into three endoscopic groups: H. pylori -negative, previous H. pylori infection (inactive gastritis), and current H. pylori infection (active gastritis). Major endoscopic findings in active gastritis are diffuse redness, enlarged folds, nodularity, mucosal swelling, and sticky mucus, while those in H pylori -related gastritis – irrespective of active or inactive status – are atrophy, intestinal metaplasia, and xanthoma.
gastroenterology & hepatology